138 related articles for article (PubMed ID: 31004504)
1. Keratin 6a mutations lead to impaired mitochondrial quality control.
Lehmann SM; Leube RE; Schwarz N
Br J Dermatol; 2020 Mar; 182(3):636-647. PubMed ID: 31004504
[TBL] [Abstract][Full Text] [Related]
2. A role for keratins in supporting mitochondrial organization and function in skin keratinocytes.
Steen K; Chen D; Wang F; Majumdar R; Chen S; Kumar S; Lombard DB; Weigert R; Zieman AG; Parent CA; Coulombe PA
Mol Biol Cell; 2020 May; 31(11):1103-1111. PubMed ID: 32213122
[TBL] [Abstract][Full Text] [Related]
3. Symptomatic mucosal involvement in pachyonychia congenita: challenges in infants and young children.
Goldberg I; Mashiah J; Kutz A; Derowe A; Warshauer E; Schwartz ME; Smith F; Sprecher E; Hansen CD
Br J Dermatol; 2020 Mar; 182(3):708-713. PubMed ID: 31777952
[TBL] [Abstract][Full Text] [Related]
4. The molecular genetic analysis of the expanding pachyonychia congenita case collection.
Wilson NJ; O'Toole EA; Milstone LM; Hansen CD; Shepherd AA; Al-Asadi E; Schwartz ME; McLean WH; Sprecher E; Smith FJ
Br J Dermatol; 2014 Aug; 171(2):343-55. PubMed ID: 24611874
[TBL] [Abstract][Full Text] [Related]
5. Genotype‒Structurotype‒Phenotype Correlations in Patients with Pachyonychia Congenita.
Wu TT; Eldirany SA; Bunick CG; Teng JMC
J Invest Dermatol; 2021 Dec; 141(12):2876-2884.e4. PubMed ID: 34116063
[TBL] [Abstract][Full Text] [Related]
6. Genetic variants in pachyonychia congenita-associated keratins increase susceptibility to tooth decay.
Duverger O; Carlson JC; Karacz CM; Schwartz ME; Cross MA; Marazita ML; Shaffer JR; Morasso MI
PLoS Genet; 2018 Jan; 14(1):e1007168. PubMed ID: 29357356
[TBL] [Abstract][Full Text] [Related]
7. SiRNA-mediated selective inhibition of mutant keratin mRNAs responsible for the skin disorder pachyonychia congenita.
Hickerson RP; Smith FJ; McLean WH; Landthaler M; Leube RE; Kaspar RL
Ann N Y Acad Sci; 2006 Oct; 1082():56-61. PubMed ID: 17145926
[TBL] [Abstract][Full Text] [Related]
8. Rapamycin selectively inhibits expression of an inducible keratin (K6a) in human keratinocytes and improves symptoms in pachyonychia congenita patients.
Hickerson RP; Leake D; Pho LN; Leachman SA; Kaspar RL
J Dermatol Sci; 2009 Nov; 56(2):82-8. PubMed ID: 19699613
[TBL] [Abstract][Full Text] [Related]
9. A spectrum of mutations in keratins K6a, K16 and K17 causing pachyonychia congenita.
Liao H; Sayers JM; Wilson NJ; Irvine AD; Mellerio JE; Baselga E; Bayliss SJ; Uliana V; Fimiani M; Lane EB; McLean WH; Leachman SA; Smith FJ
J Dermatol Sci; 2007 Dec; 48(3):199-205. PubMed ID: 17719747
[TBL] [Abstract][Full Text] [Related]
10. Gene expression profiling in pachyonychia congenita skin.
Cao YA; Hickerson RP; Seegmiller BL; Grapov D; Gross MM; Bessette MR; Phinney BS; Flores MA; Speaker TJ; Vermeulen A; Bravo AA; Bruckner AL; Milstone LM; Schwartz ME; Rice RH; Kaspar RL
J Dermatol Sci; 2015 Mar; 77(3):156-65. PubMed ID: 25656049
[TBL] [Abstract][Full Text] [Related]
11. Revisiting pachyonychia congenita: a case-cohort study of 815 patients.
Samuelov L; Smith FJD; Hansen CD; Sprecher E
Br J Dermatol; 2020 Mar; 182(3):738-746. PubMed ID: 31823354
[TBL] [Abstract][Full Text] [Related]
12. Pachyonychia congenita patients with mutations in KRT6A have more extensive disease compared with patients who have mutations in KRT16.
Spaunhurst KM; Hogendorf AM; Smith FJ; Lingala B; Schwartz ME; Cywinska-Bernas A; Zeman KJ; Tang JY
Br J Dermatol; 2012 Apr; 166(4):875-8. PubMed ID: 22098151
[TBL] [Abstract][Full Text] [Related]
13. Pachyonychia congenita: a case report of a successful treatment with rosuvastatin in a patient with a KRT6A mutation.
Abdollahimajd F; Rajabi F; Shahidi-Dadras M; Saket S; Youssefian L; Vahidnezhad H; Uitto J
Br J Dermatol; 2019 Sep; 181(3):584-586. PubMed ID: 30307612
[TBL] [Abstract][Full Text] [Related]
14. A review of the clinical phenotype of 254 patients with genetically confirmed pachyonychia congenita.
Eliason MJ; Leachman SA; Feng BJ; Schwartz ME; Hansen CD
J Am Acad Dermatol; 2012 Oct; 67(4):680-6. PubMed ID: 22264670
[TBL] [Abstract][Full Text] [Related]
15. Keratin gene mutations in disorders of human skin and its appendages.
Chamcheu JC; Siddiqui IA; Syed DN; Adhami VM; Liovic M; Mukhtar H
Arch Biochem Biophys; 2011 Apr; 508(2):123-37. PubMed ID: 21176769
[TBL] [Abstract][Full Text] [Related]
16. Development of skin-humanized mouse models of pachyonychia congenita.
García M; Larcher F; Hickerson RP; Baselga E; Leachman SA; Kaspar RL; Del Rio M
J Invest Dermatol; 2011 May; 131(5):1053-60. PubMed ID: 21150925
[TBL] [Abstract][Full Text] [Related]
17. Identification of clinically useful predictive genetic variants in pachyonychia congenita.
Samuelov L; Sarig O; Adir N; Pavlovsky M; Smith FJ; Schwartz J; Hansen CD; Sprecher E
Clin Exp Dermatol; 2021 Jul; 46(5):867-873. PubMed ID: 33486795
[TBL] [Abstract][Full Text] [Related]
18. A novel H1 mutation in keratin 6a in an infant with pachyonychia congenita.
Luo S; Luo Q; Zhang H; Wan C
Indian J Dermatol Venereol Leprol; 2015; 81(4):385-7. PubMed ID: 26087092
[TBL] [Abstract][Full Text] [Related]
19. A KRT6A mutation p.Ile462Asn in a Chinese family with pachyonychia congenita, and identification of maternal mosaicism: a case report.
Li Y; Wang Y; Ming Y; Chaolan P; Jia Z; Cheng N; Qiaoyu C; Li M; Tianyi X
BMC Med Genomics; 2021 Nov; 14(1):259. PubMed ID: 34724947
[TBL] [Abstract][Full Text] [Related]
20. [The 521 T--> C mutation in the keratin 6A gene in a pedigree with pachyonychia congenita type I].
Yang L; Li M; Lai M; Ni J
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2010 Feb; 27(1):66-8. PubMed ID: 20140871
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
